Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis

NCT00016458 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis

Interventions

DRUG: anti-thymocyte globulin
DRUG: cyclophosphamide

Sponsor

Fred Hutchinson Cancer Center